Patrick Jackson, MD, Discusses Paxlovid in The Conversation

May 18, 2022 by

Patrick Jackson, MDPatrick Jackson, Assistant Professor in the Department of Medicine’s division of  Infectious Diseases and International Health, has helped care for hundreds of COVID-19 patients and assisted in Paxlovid clinical trials. The Conversation asked him to explain what the drug does and what impact greater availability may have in the fight against the coronavirus. Read the article.

Filed Under: Clinical, Media Highlights